Current scenario of drug package inserts in India and the need for their revision

Manali Mangesh Mahajan, Sujata Dudhgaonkar, Swapnil Narayan Deshmukh


Accurate and reliable drug information is essential for safe and effective use of marketed products. The primary source of drug information is a package insert (PI). It is a printed leaflet that contains information based on regulatory guidelines for the safe and effective use of a drug. It is also known as prescription drug label or prescribing information. A good PI contains approved, essential, and accurate information about the drug. It is written in a language that is not promotional, false, or misleading. It is evidence-based and updated time to time as relevant pre-clinical and clinical data become available.


Package insert, Drug

Full Text:



Ved JK. Package inserts in India: need for a revision. Int J Pharm Sci Res. 2010;1(11):454-6.

The Drugs and Cosmetics Act and Rules. Ministry of Health and Family Welfare, Government of India; 2003: 312. Available at & cact121.pdf. Accessed 15 March 2013.

Kalam A. Drug package inserts in India: current scenario. World J Pharm Pharm Sci. 2014;3(4):385-92.

Government of India. Ministry of Health and Family Welfare. Drug and Cosmetics Rules; 1940: 312. Available at and CosmeticAct.pdf. Accessed 28 July 2012.

Basak SC, van Mil JW, Sathyanarayana D. The changing roles of pharmacists in community pharmacies: perception of reality in India. Pharm World Sci. 2009;31(6):612-8.

Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Educ Couns. 2007;67(1-2):157-68.

Pander Maat H, Lentz L. Improving the usability of patient information leaflets. Patient Educ Couns. 2010;80(1):113-9.

Dual labelling on drug packs made voluntary. Available at Accessed 21 July 2012.

Dowse R, Ehlers M. Medicine labels incorporating pictograms: do they influence understanding and adherence? Patient Educ Couns. 2005;58(1):63-70.